Foundation for Adenosine Research
Public records show a registered, tax-exempt organization in good standing.
What it says it does
To advance scientific understanding and innovation in the field of adenosine biology by supporting the exploration of adenosine's role in human health and disease, fostering collaboration across disciplines, and accelerating discoveries into transformative therapies for the benefit of patients and society, as well as the making of distributions to organizations that qualify as exempt organizations under the Internal Revenue Code.
- Income
- $75,000
- Spending
- $45,655
- Reserves
- 7.7 months of spending
- Largest source of income
- donations and private grants, 100%
Source: Form 990EZ for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Financial health
We do not score finances when yearly spending is very small or the return has too little detail. The ratios stop meaning much at that size.
Source: Form 990EZ for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Governance
This organization files the short tax form, which does not ask about boards, policies or audits. That is normal for a small charity and is not a mark against it.
Source: Form 990EZ for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (4)
- Research Grantmaking and Scientific Program Support. 70 percent of total activity and 85-88 percent of expenses. FAR awards research grants and provides targeted financial support for early stage scientific investigations in adenosine biology. Grants are designed to support hypothesis-driven preclinical and translational research, including pilot studies, proof-of-concept experiments, and data generation necessary to advance understanding of adenosine signaling in areas such as oncology, autoimmune disease, inflammation, and metabolic disorders. Scientific review and funding recommendations are supported by external scientific advisors and, beginning in 2026, a formal Scientific Advisory Council composed of independent subject-matter experts who serve as unpaid volunteers. Funded research activities are conducted at third-party academic institutions, nonprofit research organizations, and qualified research laboratories in the US. FAR does not operate laboratory facilities. Activity is funded entirely through charitable donations. Expenses are allocable to research grants, pilot studies, and associated scientific program support. Activity directly furthers FAR's scientific and educational purposes by advancing basic and translational research related to adenosine biology. Funding early stage research reduces barriers to discovery, promotes dissemination of scientific knowledge, and accelerates progress toward therapies that benefit public health.
- ACCORD (Adenosine Cancer Collaborative for Oncology Research and Discovery). 10 percent of total activity and 5-8 percent of expenses. FAR convenes and supports ACCORD, a structured scientific collaboration focused on the role of adenosine signaling in cancer biology and treatment. ACCORD facilitates coordinated data review, prioritization of research questions and alignment of preclinical research efforts across participating investigators. The activity includes invited academic researchers, clinicians and scientific advisors. ACCORD activities are conducted through virtual meetings and periodic in-person scientific convenings hosted at partner academic or research institutions. ACCORD is funded through charitable donations. Expenses are primarily for meeting coordination, scientific review support, and limited pilot study funding. By fostering collaboration and coordination among researchers, ACCORD enhances scientific efficiency, reduces duplication of effort, and promotes the generation and dissemination of new scientific knowledge related to cancer biology and treatment.
- Scientific Advisory and Educational Convenings. 10 percent of total activity and 5-7 percent of expenses. FAR organizes scientific workshops, advisory meetings, and structured educational convenings to review emerging research, define research priorities and educate stakeholders on advances in adenosine biology. Convenings are focused on scientific exchange and strategic research planning. Activities include participation from volunteer scientific advisors, academic researchers, and clinicians. FAR's Scientific Advisory Council will participate on an unpaid, volunteer basis. Activities are conducted through virtual platforms and occasional in-person meetings hosted at academic or nonprofit venues. Funded through charitable donations. These activities further FAR's educational and scientific mission by promoting knowledge sharing, supporting informed research decision-making and advancing understanding of adenosine-related biology and disease mechanisms.
- $3,155 spent. Governance, Compliance, and Organizational Operations. 10 percent of total activity and 5-10 percent of expenses. FAR maintains essential governance, compliance and administrative operations, including board management, financial oversight, regulatory filings, donor stewardship and organizational planning. Professional service providers (legal, accounting, insurance) are engaged as needed. Administrative activities are conducted remotely and through third-party service providers. Funded through charitable donations. Effective governance and compliance ensures FAR operates exclusively for charitable and scientific purposes and maintains accountability to donors and the public.
Source: Form 990EZ for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.
Are donations tax-deductible? Passed.
On the IRS list of organizations eligible to receive tax-deductible contributions.
Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending December 2025.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
How long has it been tax-exempt? Worth knowing.
Recognized by the IRS in April 2026. It is too new to have a track record.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.